To study the effect of Habb-e-Ghafis in patients with Non-Alcoholic fatty liver disease

Phase 2

• Conditions: Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

• Registration Number: CTRI/2022/01/039497
• Lead Sponsor: Central Council for Research in Unani Medicine New Dehli

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 February 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Ultrasonography (USG) documented grade 1 (mild) and grade 2 (moderate) non-alcoholic fatty liver disease.

2. Patients with dull ache/heaviness in the right hypochondriac region.

3. Patients irrespective of gender.

4. Patients in the age group of 20 to 60.

5. Body Mass Index (BMI) < 35 kg/m2.

6. Patients willing to sign written informed consent.

Exclusion Criteria

1. Patients below the age of 20 years and above 60 years.

2. Grade 3 fatty liver or above.

3. Prior diagnosis of chronic liver disease other than NAFLD including autoimmune, viral and alcoholic liver disease.

4. Patients having fulminant hepatitis and drug induced hepatitis.

5. Prior diagnosis of liver cirrhosis.

6. History of liver transplantation.

7. Body Mass Index (BMI) > 35kg/m2

8. Pregnant or breastfeeding mothers.

9. Active case of malignancy.

10. Patients having cholelithiasis or cholecystitis.

11. Patients having Diabetes Mellitus.

12. Patients with cardiovascular or renal diseases.

13. Unwillingness or inability to fulfill the protocol.

14. Patients who fail to give consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified